Clinical Trials Directory

Trials / Completed

CompletedNCT03387956

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting

Intravenous Dexamethasone Combined With Intrathecal Atropine to Prevent Morphine-related Nausea and Vomiting After Cesarean Delivery: A Randomized Double-blinded Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and vomiting.

Detailed description

One of the gold standards for analgesia following cesarean delivery is intrathecal morphine, which is not devoid of complications namely postoperative nausea and vomiting. We evaluated the antiemetic effect of intravenous dexamethasone combined with intrathecal atropine after cesarean delivery under spinal bupivacaine plus morphine anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGIntrathecal atropine100ug intrathecal atropine will be injected with spinal anesthesia
DRUGdexamethasoneintravenous 8 mg dexamethasone (2ml).

Timeline

Start date
2017-03-20
Primary completion
2017-07-28
Completion
2017-08-10
First posted
2018-01-02
Last updated
2018-06-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03387956. Inclusion in this directory is not an endorsement.

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting (NCT03387956) · Clinical Trials Directory